Ethiopia vs Latvia: Previously treated cases tested for RR-/MDR-TB
Ethiopia
78.0%
in 2024
Latvia
80.0%
in 2022
Ethiopia rank
117th
Latvia rank
114th
Previously treated cases tested for RR-/MDR-TB over time
- Ethiopia
- Latvia
How they compare
Latvia currently reports 80.0% against 78.0% in Ethiopia, a difference of 2.0%.
The two have swapped places 2 times across 8 shared years of data; in 2007 it was Latvia ahead.
Ethiopia ranks 117th and Latvia ranks 114th of 180 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.2% | 92.5% | 83.3% | Latvia |
| 2010s | 43.5% | 89.2% | 45.7% | Latvia |
| 2020s | 88.0% | 92.0% | 4.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ethiopia or Latvia?
- Latvia, at 80.0% against 78.0% in Ethiopia as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ethiopia and Latvia?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Ethiopia and Latvia?
- 8 years are reported by both, from 2007 to 2021.
- How do Ethiopia and Latvia rank globally for previously treated cases tested for rr-/mdr-tb?
- Ethiopia ranks 117th and Latvia ranks 114th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.